Innate and Adaptive Immune Consequences of Necroptosis
Innate and Adaptive Immune Consequences of Necroptosis
批准号:
10043494
负责人:
Julie Magarian Blander
金额:
$25.43万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-17 至 2022-05-31
关键词:
Acute Lung InjuryAlzheimer&aposs DiseaseAmyotrophic Lateral SclerosisAnimal ModelAntigensApoptosisApoptoticAtherosclerosisAutoimmune DiseasesAutoimmune ProcessAutoimmunityBrain IschemiaCASP8 geneCD4 Positive T LymphocytesCardiovascular DiseasesCell DeathCell Differentiation processCell divisionCell membraneCell physiologyCellsCessation of lifeCharacteristicsChronicChronic lung diseaseComplexCrohn&aposs diseaseDevelopmentDietDigestive System DisordersDiseaseDown-RegulationEmbryoEnvironmental Risk FactorEpithelialEpithelial CellsEpitheliumEquilibriumEventFoundationsFunctional disorderGene Expression ProfileGene Expression ProfilingGenerationsGenetic Predisposition to DiseaseGenetic TranscriptionGenetically Engineered MouseHomeostasisHumanImmuneImmune ToleranceImmune systemImmunityImmunosuppressionIn VitroInfectionInfection ControlInflammationInflammation MediatorsInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInjuryInnate Immune SystemIntestinesIschemiaKnowledgeLamina PropriaLife StyleLymphoid CellMalignant NeoplasmsMediatingMediator of activation proteinModelingMolecularMononuclearMucous MembraneMultiple SclerosisMusMyocardial IschemiaNamesNatureNerve DegenerationNormal tissue morphologyOrganOrgan ModelOrgan failureParkinson DiseasePathologicPathologyPathway interactionsPatientsPatternPhagocytesPhagocytosisPhosphotransferasesPhysiologyPopulationProcessProductionProtein-Serine-Threonine KinasesProteinsPublishingRIPK1 geneRIPK3 geneReportingSamplingSignal TransductionSmall IntestinesSterilitySwellingSystemic Lupus ErythematosusT cell differentiationTNF geneTherapeutic InterventionTissuesTransgenesUlcerative ColitisViralWorkadaptive immune responsebasechronic inflammatory diseasecommensal microbesdesigndimergenome wide association studyimprintin vivoinflammatory disease of the intestineinnate immune functionintestinal epitheliumintestinal homeostasismacrophagemesenteric lymph nodemicrobiotamouse modelnervous system disordernovelnovel therapeuticspathogenic microbepreservationprogramsreceptorrenal ischemiaresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROPOSAL SUMMARY
The innate immune system responds to perturbations in tissue homeostasis resultant from infection but also
dying cells and tissue damage. Cells die by different modes of programmed cell death including apoptosis and
necroptosis. Cell death by apoptosis is a normal component of healthy tissue physiology that is balanced by cell
division and maintains normal tissue size and function. Cell death by apoptosis is tolerogenic and non-
inflammatory, and contrasts with necroptosis, which is pathological and inflammatory. Necroptosis involves the
formation of a complex of receptor interacting serine/threonine protein kinases RIPK1, RIPK3 and the
necroptosis effector mixed lineage kinase domain-like protein (MLKL). Up until recently, necroptosis was thought
to function primarily in the control of infection and mainly as a fail-safe strategy that counters viral blockade of
apoptosis. Studies in mouse models, however, have shown that deficiency in components of the apoptosis
machinery such as caspase-8 or FADD leads to embryonic lethality driven by necroptosis and dependent on
RIPK3 and MLKL. Other studies using conditional deletion of caspase-8 or FADD in the intestinal epithelium
revealed that blocking the pathways that mediate homeostatic apoptosis precipitates intestinal inflammation
associated with elevated levels of RIPK3 and necroptosis. Indeed, a notable increase in programmed cell death
of intestinal epithelial cells (IEC) has been reported in patients with inflammatory bowel disease (IBD), and this
damage is associated with heightened inflammation and increased levels of tumor necrosis factor (TNF)-a, an
important mediator of cell death. Using a novel mouse model where we can inducibly trigger necroptosis of IEC,
we will determine how IEC necroptosis impacts intestinal homeostasis and we will define the nature of the
inflammatory response. Our previous work has established that homeostatic apoptosis within the intestinal
epithelium is a major driver of immune suppression and tolerance, imprinting intestinal mononuclear phagocytes
(MNP) with ‘suppression of inflammation’ and ‘induction of regulatory CD4 T cell’ transcriptional signatures. Here
we will define how necroptosis impacts MNP responses. We will examine the composition and characteristics of
the small intestinal MNP population that responds to necroptotic IEC and decipher its function in various innate
immune functions relating to the production of inflammatory mediators, modulation of innate lymphoid cell
function as well as the CD4 T helper cell differentiation. The knowledge we gain will define how necroptosis
drives inflammatory responses by innate and adaptive populations of cells, serve as a roadmap for the
consequences of necroptosis in other tissues, and lay the foundation for the development of novel therapeutics
for chronic inflammatory diseases such as IBD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mobilizing TAP-independent CD8 T cells through non-canonical cross-presentation
-
批准号:10659785
-
项目类别:
-
资助金额:$67.69万
-
财政年份:2023
-
负责人:Julie Magarian Blander
-
依托单位:
Modulating XIAP for the Treatment of Inflammatory Bowel Disease
-
批准号:10727185
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2023
-
负责人:Julie Magarian Blander
-
依托单位:
Toll-like receptor control of endocytic antigen cross-presentation
-
批准号:10735354
-
项目类别:
-
资助金额:$67.56万
-
财政年份:2023
-
负责人:Julie Magarian Blander
-
依托单位:
Toll-like Receptor Control of MHC Class I Endocytosis
-
批准号:10557150
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2022
-
负责人:Julie Magarian Blander
-
依托单位:
Toll-like Receptor Control of MHC Class I Endocytosis
-
批准号:10453097
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2022
-
负责人:Julie Magarian Blander
-
依托单位:
Innate and Adaptive Immune Consequences of Necroptosis
-
批准号:10196978
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2020
-
负责人:Julie Magarian Blander
-
依托单位:
Role of apoptosis in the intestinal epithelium during homeostasis and disease
-
批准号:9926879
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2017
-
负责人:Julie Magarian Blander
-
依托单位:
Non-Canonical Cross-presentation in Dendritic Cells Upon TAP Blockade
-
批准号:9404238
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2017
-
负责人:Julie Magarian Blander
-
依托单位:
Novel vita-vaccine formula combines safety of dead and efficacy of live vaccines
-
批准号:9357501
-
项目类别:
-
资助金额:$41.93万
-
财政年份:2016
-
负责人:Julie Magarian Blander
-
依托单位:
Control of protective immunity by innate pathways sensing bacterial viability
-
批准号:8295078
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Julie Magarian Blander
-
依托单位:
Control of protective immunity by innate pathways sensing bacterial viability
-
批准号:8702913
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Julie Magarian Blander
-
依托单位:
Control of protective immunity by innate pathways sensing bacterial viability
-
批准号:8883342
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2012
-
负责人:Julie Magarian Blander
-
依托单位:
Control of protective immunity by innate pathways sensing bacterial viability
-
批准号:8528462
-
项目类别:
-
资助金额:$39.83万
-
财政年份:2012
-
负责人:Julie Magarian Blander
-
依托单位:
Innate Immune Sensing of Microbial Viability
-
批准号:7860326
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2009
-
负责人:Julie Magarian Blander
-
依托单位:
Innate Immune Sensing of Microbial Viability
-
批准号:7737713
-
项目类别:
-
资助金额:$21.19万
-
财政年份:2009
-
负责人:Julie Magarian Blander
-
依托单位:
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
-
批准号:8076388
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2008
-
负责人:Julie Magarian Blander
-
依托单位:
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
-
批准号:7525361
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2008
-
负责人:Julie Magarian Blander
-
依托单位:
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
-
批准号:8278660
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2008
-
负责人:Julie Magarian Blander
-
依托单位:
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
-
批准号:7628056
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2008
-
负责人:Julie Magarian Blander
-
依托单位:
The Regulatory Control Mechanisms of Cross-presentation by Toll-like Receptors
-
批准号:7869320
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2008
-
负责人:Julie Magarian Blander
-
依托单位: